Clinical Trial Update: Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating Upadacitinib for Relapsing Polychondritis, with efficacy, safety and immunological assessments, and the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Polychondritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Relapsing Polychondritis | Phase 1, Phase 2 | Status: RECRUITING